{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:33:29Z","timestamp":1782891209762,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1038\/s41371-021-00544-1","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T07:04:10Z","timestamp":1620371050000},"page":"537-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Persistence of uncontrolled hypertension post-cardiac rehabilitation in stable coronary patients"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6041-4761","authenticated-orcid":false,"given":"Thierry","family":"Denolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8712-0766","authenticated-orcid":false,"given":"Claude","family":"Pellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Laure","family":"Serandour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Revault d\u2019Allonnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"544_CR1","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0140-6736(99)04021-0","volume":"353","author":"H Tunstall-Pedoe","year":"1999","unstructured":"Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547\u201357.","journal-title":"Lancet"},{"key":"544_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/CIRCRESAHA.116.309115","volume":"120","author":"GA Mensah","year":"2017","unstructured":"Mensah GA, Wei GS, Sortie PD, Fine LJ, Rosenberg Y, Kaufmann PG, et al. Decline in cardiovascular mortality: possible causes and implications. Circ Res. 2017;120:366\u201380.","journal-title":"Circ Res"},{"key":"544_CR3","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jacc.2017.02.050","volume":"69","author":"G Lemesle","year":"2017","unstructured":"Lemesle G, Tricot O, Meurice T, Lallemant R, Delomez M, Equine O, et al. Incident myocardial infarction and very late stent thrombosis in outpatients with stable coronary artery disease. J Am Coll Cardiol. 2017;69:2149\u201356.","journal-title":"J Am Coll Cardiol"},{"key":"544_CR4","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1093\/eurheartj\/ehn478","volume":"29","author":"RH Mehta","year":"2008","unstructured":"Mehta RH, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, on behalf of the REACH Registry Investigators, et al. Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur Heart J. 2008;29:3052\u201360.","journal-title":"Eur Heart J"},{"key":"544_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(00)04235-5","volume":"357","author":"EUROASPIRE I and II Group.","year":"2001","unstructured":"EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001;357:995\u20131001.","journal-title":"Lancet"},{"key":"544_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/HJR.0b013e3283294b1d","volume":"16","author":"K Kotseva","year":"2009","unstructured":"Kotseva K, Wood D, De Backer G, De Bacquer D, Py\u00f6r\u00e4l\u00e4 K, Keil U, on behalf of EUROASPIRE III Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009;16:121\u201337.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"544_CR7","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1177\/2047487316667784","volume":"23","author":"K Kotseva","year":"2016","unstructured":"Kotseva K, De Bacquer D, De Backer G, Ryd\u00e9n L, Jennings C, Gyberg V, et al. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol. 2016;23:2007\u201318.","journal-title":"Eur J Prev Cardiol"},{"key":"544_CR8","first-page":"170","volume":"10","author":"AL Perrine","year":"2018","unstructured":"Perrine AL, Lecoffre C, Blacher J, Olie V. L\u2019hypertension art\u00e9rielle en France: pr\u00e9valence, traitement et contr\u00f4le en 2015 et \u00e9volutions depuis 2006. Bull Epidemiol Hebd. 2018;10:170\u20139.","journal-title":"Bull Epidemiol Hebd"},{"key":"544_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/fcp.12044","volume":"28","author":"J Blacher","year":"2014","unstructured":"Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B,French Society of Hypertension, et al. Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam Clin Pharm. 2014;28:1\u20139.","journal-title":"Fundam Clin Pharm"},{"key":"544_CR10","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:2199\u2013269.","journal-title":"J Am Coll Cardiol"},{"key":"544_CR11","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti-Rosei E, Azizi M, Burnier M,Authors\/Task Force Members, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953\u20132041.","journal-title":"J Hypertens"},{"key":"544_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.acvd.2012.01.010","volume":"105","author":"B Pavy","year":"2012","unstructured":"Pavy B, Iliou MC, Verg\u00e8s-Patois B, Brion R, Monp\u00e8re C, Carr\u00e9 F, et al. French Society of Cardiology guidelines for cardiac rehabilitation in adults; Exercise, Rehabilitation Sport Group (GERS); French Society of Cardiology. Arch Cardiovasc Dis. 2012;105:309\u201328.","journal-title":"Arch Cardiovasc Dis"},{"key":"544_CR13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jacc.2007.04.033","volume":"50","author":"RJ Thomas","year":"2007","unstructured":"Thomas RJ, King M, Lui K, Oldridge N, Pi\u00f1a IL, Spertus J, et al. AACVPR\/ACC\/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation\/secondary prevention services. J Am Coll Cardiol. 2007;50:1400\u201333.","journal-title":"J Am Coll Cardiol"},{"key":"544_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ancard.2017.04.005","volume":"66","author":"T Denolle","year":"2017","unstructured":"Denolle T, Dib M, Brune M, Nicolas S, Richard A, Auguste V, et al. Control of cardiovascular risk factors in coronary patients one year after cardiac rehabilitation. Ann Cardiol Angeiol. 2017;66:135\u20139.","journal-title":"Ann Cardiol Angeiol"},{"key":"544_CR15","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1097\/HJH.0000000000002130","volume":"37","author":"R C\u00edfkov\u00e1","year":"2019","unstructured":"C\u00edfkov\u00e1 R, L\u00e1nsk\u00e1 V, Bruthans J, Mayer O,Jr, Kotseva K, Wood D, et al. Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry. J Hypertens. 2019;37:2015\u201323.","journal-title":"J Hypertens"},{"key":"544_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/2047487318825350","volume":"26","author":"K Kotseva","year":"2019","unstructured":"Kotseva K, De Backer G, De Bacquer D, Ryd\u00e9n L, Hoes A, Grobbee D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V Registry. Eur J Prev Cardiol. 2019;26:824\u201335.","journal-title":"Eur J Prev Cardiol"},{"key":"544_CR17","doi-asserted-by":"publisher","first-page":"i4801","DOI":"10.1136\/bmj.i4801","volume":"354","author":"E Puymirat","year":"2016","unstructured":"Puymirat E, Riant E, Aissaoui N, Soria A, Ducrocq G, Coste P, et al. \u03b2 blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study. BMJ. 2016;354:i4801.","journal-title":"BMJ"},{"key":"544_CR18","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1056\/NEJMoa042739","volume":"351","author":"E Braunwald","year":"2004","unstructured":"Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J,PEACE Trial Investigators, et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Eng J Med. 2004;351:2058\u201368.","journal-title":"N Eng J Med"},{"issue":"Suppl 2","key":"544_CR19","first-page":"S15","volume":"9","author":"J Hosie","year":"1995","unstructured":"Hosie J, Wiklund I. Managing hypertension in general practice: can we do better? J Hum Hypertens. 1995;9(Suppl 2):S15\u20138.","journal-title":"J Hum Hypertens"},{"key":"544_CR20","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","volume":"388","author":"E Vidal-Petiot","year":"2016","unstructured":"Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC,CLARIFY Investigators, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388:2142\u201352.","journal-title":"Lancet"},{"key":"544_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/HYPERTENSIONAHA.117.10204","volume":"71","author":"E Vidal-Petiot","year":"2018","unstructured":"Vidal-Petiot E, Greenlaw N, Ford I, Ferrari R, Fox KM, Tardif JC, et al. Relationships between components of blood pressure and cardiovascular events in patients with stable coronary artery disease and hypertension. Hypertension. 2018;71:168\u201376.","journal-title":"Hypertension"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00544-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00544-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00544-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T14:03:50Z","timestamp":1655993030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00544-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1038\/s41371-021-00544-1","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,7]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TD has received a grant from Servier for participation in a hypertension congress, and from Sanofi, Novartis and Menarini. CP, ALS, SL and FRA have no competing interests to declare with respect to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}